Spatial Genomics & Transcriptomics Market
Number of pages: 100 | Report Format: PDF | Published date: March 22, 2023
Historical Years – 2021 | Base Year – 2022 | Forecasted Years – 2023-2031
|
Report Attribute |
Details |
|
Market Size Value in 2022 |
US$ 365 million |
|
Revenue Forecast in 2031 |
US$ 1,398.9 million |
|
CAGR |
16.1% |
|
Base Year for Estimation |
2022 |
|
Forecast Period |
2023-2031 |
|
Historical Year |
2021 |
|
Segments Covered |
Technique, Product, End-user, and Region |
|
Regional Scope |
North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa |
According to the deep-dive market assessment study by Growth Plus Reports, the global spatial genomics & transcriptomics market was valued at US$ 365 million in 2022 and is expected to register a revenue CAGR of 16.1% to reach US$ 1,398.9 million by 2031.
Spatial Genomics & Transcriptomics Market Fundamentals
Spatial genomics and transcriptomics is an emerging field of research that combines genomics and spatial imaging techniques to study the spatial organization of gene expression within tissues and cells. Spatial genomics and transcriptomics enable researchers to map the expression of thousands of genes to specific tissue regions, providing insights into the complex molecular interactions that underlie cell and tissue function. Researchers can better understand disease development and progression mechanisms by studying gene expression patterns within a spatial context.
The development of new imaging and sequencing technologies, coupled with advances in data analysis and interpretation tools, enables researchers to generate spatially resolved gene expression data at an unprecedented scale and resolution. Spatial genomics and transcriptomics have numerous applications in research and clinical settings, including developing new therapies and diagnostic tools for various diseases, such as cancer, neurological disorders, and autoimmune diseases. Overall, spatial genomics and transcriptomics represent a powerful approach to studying the complex molecular interactions that underlie cell and tissue function.
[5756]
Spatial Genomics & Transcriptomics Market Dynamics
The increasing prevalence of cancer globally is the major driver for the revenue growth of the global spatial genomics & transcriptomics market. Spatial genomics and transcriptomics can provide new insights into the heterogeneity of cancer cells within tumors and the interactions between cancer cells and the surrounding microenvironment. For instance, according to the WHO’s February 2022 factsheet, cancer is one of the leading causes of death, which caused about 10 million deaths in 2020. Advances in imaging techniques, such as fluorescence in situ hybridization, immunohistochemistry, and multiplex imaging, have enabled visualization of spatially resolved gene expression patterns in tissues and cells, fueling the revenue growth of the spatial genomics & transcriptomics market. Additionally, spatial genomics and transcriptomics have the potential to provide new insights into the molecular mechanisms underlying disease and to identify new targets for drug discovery. This drives the demand for spatial genomics and transcriptomics technologies in personalized medicine, thus leading to market revenue growth. Key market participants are concentrating their efforts on growing their spatial transcriptomics and genomics footprints through strategic alliances and collaborations with other companies, which is also helping the revenue growth of the global spatial genomics & transcriptomics market.
However, spatial genomics and transcriptomics technologies are still relatively new and are often expensive to implement. The high cost of these technologies may limit their adoption in some research and clinical settings. Furthermore, spatial genomics and transcriptomics generate large amounts of complex data that require advanced analytical tools to interpret. The complexity of data analysis may limit the adoption of these technologies in some research and clinical settings. Additionally, the limited availability of skilled professionals and competition from traditional methods impede the overall spatial genomics & transcriptomics market revenue growth.
Spatial Genomics & Transcriptomics Market Ecosystem
The global spatial genomics & transcriptomics market is analyzed from four perspectives: technique, product, end-user, and region.
Spatial Genomics & Transcriptomics Market by Technique
[75645]
Based on the technique, the global spatial genomics & transcriptomics market is segmented into spatial transcriptomics and spatial genomics.
The spatial transcriptomics segment dominated the market with the principal revenue share in 2022, attributed to increasing demand for more precise and comprehensive analysis of gene expression data. Spatial transcriptomics involves mapping gene expression data to specific tissue regions to analyze gene expression patterns within a spatial context. It enables researchers to study gene expression patterns and interactions within cells and tissues, providing insights into disease development and progression mechanisms.
Spatial transcriptomics involves several key steps, including sample preparation, spatial mapping, data analysis, and biological interpretation. In sample preparation, tissue samples are prepared and sectioned for spatial transcriptomics analysis, ensuring that gene expression data can be accurately mapped to specific tissue regions. Later in spatial mapping, it generates spatially resolved gene expression data, allowing researchers to visualize gene expression patterns within cells and tissues. Spatial transcriptomics data is analyzed using various computational tools to identify differentially expressed genes, gene expression patterns, and gene networks. Lastly, the results of spatial transcriptomics analysis are used to generate hypotheses and testable predictions about the underlying mechanisms of disease development and progression. These factors contribute to the revenue growth of the spatial transcriptomics segment.
Spatial Genomics & Transcriptomics Market by Product
Based on the product, the global spatial genomics & transcriptomics market is segmented into instruments, consumables, and software.
The consumables segment dominated the market with the key revenue share in 2022, as it provides the necessary tools and materials to analyze spatially resolved gene expression data. Consumables include a wide range of products, such as reagents, kits, probes, assays, and other consumables used in the sample preparation, amplification, and analysis of spatially resolved gene expression data. Probes and assays are used to detect and measure the expression of specific genes or transcripts in spatially resolved gene expression data. Sample preparation kits are used to prepare tissue and cell samples for spatial genomics and transcriptomics analysis. These kits include tissue dissociation kits and cell isolation kits. Additionally, consumables such as DNA extraction kits, PCR reagents, and sequencing reagents are less expensive than the equipment required for the same processes. They can be purchased in small quantities, making them more affordable for smaller labs or research groups. They can also be tailored to specific research needs, such as DNA extraction kits designed for different types of samples or PCR reagents optimized for specific genes or target regions. These factors contribute to the revenue growth of the consumables segment.
Spatial Genomics & Transcriptomics Market by End-user
Based on the end-user, the global spatial genomics & transcriptomics market is segmented into academic customers, translational research, diagnostic customers, and pharmaceutical & biotechnology companies.
The academic customers segment is a key player in the spatial genomics & transcriptomics market, with the largest revenue share in 2022. Spatial genomic analyses are increasingly used in academic research facilities since they thoroughly examine diverse diseases. Academic customers refer to customers primarily from academic and research institutions such as universities, research institutes, and academic medical centers. Academic customers in the spatial genomics and transcriptomic market are typically interested in products and services that provide high-quality spatial resolution, accuracy, and data analysis and interpretation tools.
The translational research segment accounted for the second largest revenue share in 2022, owing to the growing usage of spatial genomics and transcriptomics to provide high-throughput data on the organizational structure of cell content from different tissues and cell types. Translational research applies basic research findings to developing clinical therapies and diagnostics. It involves spatially resolved gene expression data to identify novel therapeutic targets and biomarkers for various diseases. Spatial genomics and transcriptomics can identify drug candidates targeting specific biomarkers or therapeutic targets, accelerating drug development. Spatial genomics and transcriptomics can be used to develop personalized therapies and diagnostic tools that can be tested in clinical trials to evaluate their safety and efficacy. These factors contribute to the revenue growth of the translational research segment.
Spatial Genomics & Transcriptomics Market by Region
Geographically, the global spatial genomics & transcriptomics market has been segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.
North America dominated the global spatial genomics & transcriptomics market with the largest revenue share in 2022, attributed to strategic investments in disease pathology research, as well as a greater emphasis on transcriptomics R&D. Additionally, companies in North America are continuously involved in launching products in the spatial genomics and transcriptomics field, which is also helping in the market revenue growth. For instance, in February 2023, Curio Bioscience, a business developing a new generation of high-precision tools for the life sciences sector, announced the debut of Curio Seeker, the world’s first high-resolution, whole-transcriptome spatial mapping kit. Curio Seeker, which uses the Slide-seq technology developed by its academic co-founders at the Broad Institute of MIT and Harvard, lets any laboratory obtain whole-transcriptome spatial data from tissue samples in an easy-to-use approach. The kit allows investigators to extract as much transcriptome data as possible from their samples. The solution is interoperable with all Illumina sequencers, allowing the kit to be used in current sequencing processes with no new equipment.
Spatial Genomics & Transcriptomics Market Competitive Landscape
The prominent players operating in the global spatial genomics & transcriptomics market are:
Spatial Genomics & Transcriptomics Market Strategic Developments
The global spatial genomics & transcriptomics market is projected to reach US$ 1,398.9 million by 2031.
The increasing prevalence of cancer, strategic alliances and collaborations with other companies, and advances in imaging techniques drive revenue growth in the global spatial genomics & transcriptomics market.
The spatial genomics & transcriptomics market is expected to register a revenue CAGR of 16.1% during the forecast period from 2023 to 2031.
The limited availability of skilled professionals and competition from traditional methods restrict the global spatial genomics & transcriptomics market revenue growth.
Some prominent players operating in the global spatial genomics & transcriptomics market are PerkinElmer Inc. (Horizon Discovery Group Plc.), Seven Bridges Genomics, Naterac Inc., NanoString Technologies, Inc., and Standard BioTools.
*Insights on financial performance are subject to the availability of information in the public domain